Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 151 participants.
Also called NCT02585674
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 151 participants
- Sponsor
- Registry
-
NCT02585674 -
2014-004533-13
-
- Other papers using this trial's data
- A Randomized Controlled Trial Comparing Efficacy and Safety of Insulin Glargine 300 Units/mL Versus 100 Units/mL in Older People With Type 2 Diabetes: Results From the SENIOR Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02585674. Randomized; no masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo
- Acronym
- AUTOMATIX
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Insulin glargine (U300)
- Intervention (Device)
- MyStar DoseCoach
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct02585674- Content hash
21d2b78df19097255953d50cb6bde119a056a98eb4ad7f6533c27542340f7d0e